Q Medical Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Q medical inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Q Medical Inc Today - Breaking & Trending Today

nQ Medical, a Digital Biomarker Discovery Platform, Unveils Latest COBRE Clinical Trial Results in Cognitive Impairment Across the AD Spectrum at AAN 2021 Annual Meeting


nQ Medical, a Digital Biomarker Discovery Platform, Unveils Latest COBRE Clinical Trial Results in Cognitive Impairment Across the AD Spectrum at AAN 2021 Annual Meeting
Share Article
The Cleveland Clinic’s COBRE trial explored monitoring of passive typing tasks as an indicator of cognitive impairment across the Alzheimer’s Disease Spectrum using nQ Medical’s Digital Biomarker Discovery Platform for diseases of cognition and motor. Detailed study findings will be presented at the American Academy of Neurology (AAN) Industry Therapeutic Update on Digital Cognitive Phenotyping In Neurodegenerative Disease: Modern Metrics For Clinical Science And Practice. Data will be shared by Justin Miller, PhD, neuropsychologist, and Aaron Ritter, MD, neurologist, Lou Ruvo Center for Brain Health, Cleveland Clinic, Las Vegas, NV. ....

United States , United Kingdom , Las Vegas , Justin Miller , American Academy Of Neurology , Michaelj Fox Foundation , Q Medical Inc , Brain Health In Las Vegas , Cleveland Clinic Lou Ruvo Center , Brain Health , Disease Spectrum , American Academy , Industry Therapeutic Update , Machine Learning , Digital Biomarker Discovery Platform , Cleveland Clinic , Massachusetts General , Real World Data , Press Release , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , லாஸ் வேகாஸ் , ஜஸ்டின் மில்லர் , அமெரிக்கன் கலைக்கழகம் ஆஃப் நரம்பியல் , க்யூ மருத்துவ இன்க் , மூளை ஆரோக்கியம் இல் லாஸ் வேகாஸ் ,

nQ Medical, a Digital Biomarker Discovery Platform, Unveils Latest Alzheimer's Disease Clinical Trial Results at AD/PD 2021 International Conference


nQ Medical, a Digital Biomarker Discovery Platform, Unveils Latest Alzheimer’s Disease Clinical Trial Results at AD/PD 2021 International Conference
Share Article
nQ Medical’s Alzheimer’s Disease clinical trial studied passive typing monitoring as an indicator of cognitive impairment in the AD spectrum. Findings will be presented at the AD/PD Industry Symposium on Digital Cognitive Phenotyping in Neurodegenerative Disease: Impact of Digital on Neurology Practice.
nQ Medical s results, Alzheimer’s Disease study at Cleveland Clinic Lou Ruvo Center for Brain Health
nQ’s novel technology uses machine learning to capture and analyze an individual’s typing performance on keyboard or smartphone. Data is captured continuously, non-invasively, in a natural everyday environment, making it a very promising screening tool for early detection of Alzheimer’s disease. ....

United States , United Kingdom , Las Vegas , Michaelj Fox Foundation , Q Medical Inc , Cleveland Clinic Lou Ruvo Center , Brain Health , International Conference On Alzheimer , Gold Sponsor , International Conference , Digital Biomarker Discovery Platform , Cleveland Clinic , Massachusetts General , Real World Data , Press Release , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , லாஸ் வேகாஸ் , க்யூ மருத்துவ இன்க் , கிளீவ்லேண்ட் சிகிச்சையகம் லூ ருவோ மையம் , மூளை ஆரோக்கியம் , சர்வதேச மாநாடு ஆன் முதுமறதி , தங்கம் ஸ்பான்சர் , சர்வதேச மாநாடு , டிஜிட்டல் பயோமார்க் கண்டுபிடிப்பு நடைமேடை , கிளீவ்லேண்ட் சிகிச்சையகம் ,